Name
CEA -HLA DR4(Peptide Sequence: YSWRINGIPQQHTQV)
|
Molecular structural formula
|
Normal/Tumor
gut carcinoma(RNA)
gut carcinoma(RNA)
|
HLA
DR4(用于人类白细胞抗原 II类)
DR4(用于人类白细胞抗原 II类)
|
|
|
Peptide Sequence
YSWRINGIPQQHTQV
YSWRINGIPQQHTQV
|
|
|
Lymphocyte Stimulation
peptide
|
NCBI Gene SummaryNCBI
This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
|
GeneCards Summary
CEACAM5 (CEA Cell Adhesion Molecule 5) is a Protein Coding gene. Diseases associated with CEACAM5 include Lung Non-Small Cell Carcinoma and Bile Duct Cancer. Among its related pathways are Metabolism of proteins and Response to elevated platelet cytosolic Ca2+. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity and GPI anchor binding. An important paralog of this gene is CEACAM1.
|
UniProtKB SwissProt Summary
Cell surface glycoprotein that plays a role in cell adhesion, intracellular signaling and tumor progression (PubMed:2803308, 10910050, 10864933). Mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules, such as CEACAM6 (PubMed:2803308). Plays a role as an oncogene by promoting tumor progression; induces resistance to anoikis of colorectal carcinoma cells (PubMed:10910050). ( CEAM5_HUMAN,P06731 )
(Microbial infection) Receptor for E.coli Dr adhesins. Binding of E.coli Dr adhesins leads to dissociation of the homodimer. (CEAM5_HUMAN,P06731)
|
References
[1].Ruiz M, Kobayashi H, Lasarte JJ, Prieto J, Borrás-Cuesta F, Celis E, Sarobe P. Identification and characterization of a T-helper peptide from carcinoembryonic antigen. Clin Cancer Res. 2004 Apr 15, 10(8):2860-7. (PMID: 15102695).
|
* All products on our website are for scientific research and cannot be used in human body